A Single and Multiple Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SYH2072 Tablets

NCT07647783 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

112

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants

Interventions

DRUG: SYH2072 Tablets
DRUG: SYH2072 Placebo

Sponsor

InnovStone Therapeutics Limited